Abstract:Low vision rehabilitation aims to optimise the use of residual vision after severe vision loss, but also aims to teach skills in order to improve visual functioning in daily life. Other aims include helping people to adapt to permanent vision loss and improving psychosocial functioning. These skills promote independence and active participation in society. Low vision rehabilitation should ultimately improve quality of life (QOL) for people who have visual impairment. To assess the effectiveness of low vision rehabilitation interventions on health‐related QOL (HRQOL), vision‐related QOL (VRQOL) or visual functioning and other closely related patient‐reported outcomes in visually impaired adults. We searched relevant electronic databases and trials registers up to 18 September 2019. We included randomised controlled trials (RCTs) investigating HRQOL, VRQOL and related outcomes of adults, with an irreversible visual impairment (World Health Organization criteria). We included studies that compared rehabilitation interventions with active or inactive control. We used standard methods expected by Cochrane. We assessed the certainty of the evidence using the GRADE approach. We included 44 studies (73 reports) conducted in North America, Australia, Europe and Asia. Considering the clinical diversity of low vision rehabilitation interventions, the studies were categorised into four groups of related intervention types (and by comparator): (1) psychological therapies and/or group programmes, (2) methods of enhancing vision, (3) multidisciplinary rehabilitation programmes, (4) other programmes. Comparators were no care or waiting list as an inactive control group, usual care or other active control group. Participants included in the reported studies were mainly older adults with visual impairment or blindness, often as a result of age‐related macular degeneration (AMD). Study settings were often hospitals or low vision rehabilitation services. Effects were measured at the short‐term (six months or less) in most studies. Not all studies reported on funding, but those who did were supported by public or non‐profit funders (N = 31), except for two studies. Compared to inactive comparators, we found very low‐certainty evidence of no beneficial effects on HRQOL that was imprecisely estimated for psychological therapies and/or group programmes (SMD 0.26, 95% CI ‐0.28 to 0.80; participants = 183; studies = 1) and an imprecise estimate suggesting little or no effect of multidisciplinary rehabilitation programmes (SMD ‐0.08, 95% CI ‐0.37 to 0.21; participants = 183; studies = 2; I 2 = 0%); no data were available for methods of enhancing vision or other programmes. Regarding VRQOL, we found low‐ or very low‐certainty evidence of imprecisely estimated benefit with psychological therapies and/or group programmes (SMD ‐0.23, 95% CI ‐0.53 to 0.08; studies = 2; I 2 = 24%) and methods of enhancing vision (SMD ‐0.19, 95% CI ‐0.54 to 0.15; participants = 262; studies = 5; I 2 = 34%). Two studies using multidisciplinary rehabilitation programmes showed beneficial but inconsistent results, of which one study, which was at low risk of bias and used intensive rehabilitation, recorded a very large and significant effect (SMD: ‐1.64, 95% CI ‐2.05 to ‐1.24), and the other a small and uncertain effect (SMD ‐0.42, 95%: ‐0.90 to 0.07). Compared to active comparators, we found very low‐certainty evidence of small or no beneficial effects on HRQOL that were imprecisely estimated with psychological therapies and/or group programmes including no difference (SMD ‐0.09, 95% CI ‐0.39 to 0.20; participants = 600; studies = 4; I 2 = 67%). We also found very low‐certainty evidence of small or no beneficial effects with methods of enhancing vision, that were imprecisely estimated (SMD ‐0.09, 95% CI ‐0.28 to 0.09; participants = 443; studies = 2; I 2 = 0%) and multidisciplinary rehabilitation programmes (SMD ‐0.10, 95% CI ‐0.31 to 0.12; participants = 375; studies = 2; I 2 = 0%). Concerning VRQOL, low‐certainty evidence of small or no beneficial effects that were imprecisely estimated, was found with psychological therapies and/or group programmes (SMD ‐0.11, 95% CI ‐0.24 to 0.01; participants = 1245; studies = 7; I 2 = 19%) and moderate‐certainty evidence of small effects with methods of enhancing vision (SMD ‐0.24, 95% CI ‐0.40 to ‐0.08; participants = 660; studies = 7; I 2 = 16%). No additional benefit was found with multidisciplinary rehabilitation programmes (SMD 0.01, 95% CI ‐0.18 to 0.20; participants = 464; studies = 3; I 2 = 0%; low‐certainty evidence). Among secondary outcomes, very low‐certainty evidence of a significant and large, but imprecisely estimated benefit on self‐efficacy or self‐esteem was found for psychological therapies and/or group programmes versus waiting list or no care (SMD ‐0.85, -Abstract Truncated-

Low vision aids provision in an urban setting in Germany between 2014 and 2017: a regional population based study with healthcare claims data

Big data study using health insurance claims to predict multidisciplinary low vision service uptake

Barriers and facilitators in the referral pathways to low vision services from the perspective of patients and professionals: a qualitative study

[Vision Impairment in Retirement Homes? Healthcare Research in Inpatient Care Homes]

Health-related quality of life in working-age adults with visual impairments in Germany

Baseline Traits of Patients Presenting at a Low Vision Clinic in Shanghai, China

Evaluation of a Retinal Projection Laser Eyeware in Patients with Visual Impairment Caused by Corneal Diseases in a Randomized Trial

Confidence in low vision rehabilitation and attitudes towards further learning: A survey of UK optometrists

Characteristics of individual low-vision rehabilitation counseling among older adults: A qualitative 2-year follow-up study

Visual impairment and blindness in Hungary

Low vision rehabilitation for better quality of life in visually impaired adults.

Low vision rehabilitation services: Perceived barriers and facilitators to access for older adults with visual impairment

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections

Low vision rehabilitation program in patients with myopic macular degeneration: A case series

Low Vision Among Students Attending Schools for Blind Students in Two States of North-Central Nigeria

Participation of the elderly after vision loss

Community Survey of Low Vision in Two Communities of Beijing in China

Demographic and Clinical Characteristics of a Paediatric Low Vision Population in a Low Vision Clinic in China

Impaired visual acuity caused by uncorrected refractive errors and amblyopia in a German paediatric cohort

Commentary: Low vision devices are boon to patients with visual impairment due to retinal dystrophies

[Visual impairment and blindness caused by posterior segment diseases in Hungary in people aged 50 years and older]